Imtiaz Khokhar, MD
Internal Medicine · Lewes, DENPI 1629075387
Payments from drug & device makers
Across 22 payments — averaging $24.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$103
- Boehringer Ingelheim$100
- Kestra Medical Technology Services, Inc.$95
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$70
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$44
- CSL Behring$24
- plus $101 from 6 others
What the payments were for
- Food & beverage$537100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 6 | $103 |
| Boehringer Ingelheim | 2 | $100 |
| Kestra Medical Technology Services, Inc. | 1 | $95 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $70 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $44 |
| CSL Behring | 1 | $24 |
| Philips North America LLC | 1 | $20 |
| Portola Pharmaceuticals, LLC | 1 | $20 |
| AbbVie | 1 | $18 |
| Merck | 1 | $17 |
| AstraZeneca | 1 | $13 |
| Novartis | 1 | $12 |
How this compares
$537 in reported general payments places this provider in the 70th percentile of 477 internal medicine providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 18 | $10,409 |
| Cefdinir | 34 | $703 |
| Pantoprazole Sodium | 22 | $238 |
| Methylprednisolone | 14 | $137 |
| Furosemide | 17 | $78 |
| Prednisone | 12 | $76 |
| Metoprolol Succinate | 11 | $74 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Lewes
- Bhaskar PalekarLewes$22K
- Irene ViolaLewes$15K
- Malick IslamLewes$11K
- Charles StanislavLewes$5K
- Jennifer HurdLewes$4K
- Preachess VellahLewes$3K
- Monique YostLewes$3K
- Seth IvinsNewark$384K
- Beshara HelouGeorgetown$143K
- Tabassum SalamNewark$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.